BRCA1 and breast cancer: Treatment with cucurbitacin B can inhibit cellular proliferation of these mutant cells and the BRCA1-defective parental cells, suggesting that cucurbitacin B could be an effective anticancer agent properly used for BRCA1-defective breast cancer.